Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools.

Autor: Gaitens JM; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., Culligan M; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., Friedberg JS; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., Glass E; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., Reback M; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., Scilla KA; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., Sachdeva A; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., Atalla A; School of Medicine, University of Maryland, Baltimore, MD 21201, USA., McDiarmid MA; School of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Jazyk: angličtina
Zdroj: International journal of environmental research and public health [Int J Environ Res Public Health] 2023 Mar 11; Vol. 20 (6). Date of Electronic Publication: 2023 Mar 11.
DOI: 10.3390/ijerph20064950
Abstrakt: Mesothelioma, a cancer of mesothelial cells that line the chest, lungs, heart, and abdomen, is a relatively rare disease. In the United States, approximately 3000 individuals are diagnosed with mesothelioma annually. The primary risk factor for mesothelioma is occupational asbestos exposure which can occur decades prior to disease development, though in approximately 20% of cases, known asbestos exposure is lacking. While several other countries have developed mesothelioma registries to collect key clinical and exposure data elements to allow better estimation of incidence, prevalence, and risk factors associated with disease development, no national mesothelioma registry exists in the U.S. Therefore, as part of a larger feasibility study, a patient exposure questionnaire and a clinical data collection tool were created using a series of key informant interviews. Findings suggest that risk factor and clinical data collection via an on-line questionnaire is feasible, but specific concerns related to confidentiality, in the context of employer responsibility for exposure in the unique U.S. legal environment, and timing of enrollment must be addressed. Lessons learned from piloting these tools will inform the design and implementation of a mesothelioma registry of national scope.
Databáze: MEDLINE